scholarly article | Q13442814 |
P50 | author | Roman Hajek | Q63639209 |
P2093 | author name string | Eberhard Gunsilius | |
Gerold Untergasser | |||
Johann Kern | |||
Karin Jöhrer | |||
Andrea Brunner | |||
Richard Greil | |||
Wolfgang Willenbacher | |||
Ludek Pour | |||
Angelika Olivier | |||
Benno Postert | |||
Claudia Zelle-Rieser | |||
Rainer Biedermann | |||
Shanmugapriya Thangavadivel | |||
P2860 | cites work | CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells | Q22010907 |
CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells | Q24684754 | ||
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12 | Q27652199 | ||
NMR Analysis of the Structure, Dynamics, and Unique Oligomerization Properties of the Chemokine CCL27 | Q27660108 | ||
A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues | Q28137982 | ||
A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts | Q28184989 | ||
CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes | Q80165351 | ||
CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells | Q80542422 | ||
Many facets of bortezomib resistance/susceptibility | Q81943268 | ||
Chemokines and cancer | Q83278273 | ||
CCL27-CCR10 interactions regulate T cell-mediated skin inflammation | Q28217086 | ||
Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease | Q34103913 | ||
SDF-1 inhibition targets the bone marrow niche for cancer therapy | Q34324830 | ||
The chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma | Q34422363 | ||
Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells | Q35105929 | ||
Critical roles of chemokine receptor CCR10 in regulating memory IgA responses in intestines | Q35546730 | ||
Pathogenesis beyond the cancer clone(s) in multiple myeloma | Q35607266 | ||
Establishment of a human multiple myeloma xenograft model in the chicken to study tumor growth, invasion and angiogenesis | Q35636675 | ||
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells | Q35698582 | ||
Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation | Q35814835 | ||
Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues | Q36550817 | ||
The chemokine and chemokine receptor superfamilies and their molecular evolution | Q36698659 | ||
Proteasome inhibitors in multiple myeloma: 10 years later | Q38014395 | ||
Halting metastasis through CXCR4 inhibition | Q38065037 | ||
Targeting the bone marrow microenvironment in multiple myeloma. | Q38289041 | ||
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. | Q38308218 | ||
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks | Q38472331 | ||
The paradoxical role of IL-10 in immunity and cancer. | Q38549850 | ||
Role of the tumor microenvironment in regulating apoptosis and cancer progression. | Q38844221 | ||
Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells | Q38909786 | ||
Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target. | Q39421121 | ||
Bone Marrow-Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth in Vitro and In Vivo | Q39439676 | ||
IL-17A Induces CCL28, Supporting the Chemotaxis of IgE-Secreting B Cells | Q39568602 | ||
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27. | Q40325749 | ||
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1. | Q40574163 | ||
CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin | Q42217761 | ||
Specific tumor-stroma interactions of EBV-positive Burkitt's lymphoma cells in the chick chorioallantoic membrane | Q42547317 | ||
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. | Q44758838 | ||
Identification of the chemokine CCL28 as a growth and survival factor for human hematopoietic stem and progenitor cells | Q45885848 | ||
CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways. | Q46116498 | ||
Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. | Q48028687 | ||
The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma. | Q53947641 | ||
Chemokines and Cancer: A Fatal Attraction | Q56942343 | ||
Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop | Q71775744 | ||
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells | Q72184631 | ||
Serum interleukin-10 in plasma-cell dyscrasias | Q73202043 | ||
Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma | Q74676116 | ||
Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues | Q78826829 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 78605-78618 | |
P577 | publication date | 2016-10-08 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma | |
P478 | volume | 7 |
Q47106227 | Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. |
Q58755052 | Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level |
Search more.